Literature DB >> 26854932

Longitudinal measures of cognition in the Ts65Dn mouse: Refining windows and defining modalities for therapeutic intervention in Down syndrome.

J Luis Olmos-Serrano1, William A Tyler2, Howard J Cabral3, Tarik F Haydar4.   

Abstract

Mouse models have provided insights into adult changes in learning and memory in Down syndrome, but an in-depth assessment of how these abnormalities develop over time has never been conducted. To address this shortcoming, we conducted a longitudinal behavioral study from birth until late adulthood in the Ts65Dn mouse model to measure the emergence and continuity of learning and memory deficits in individuals with a broad array of tests. Our results demonstrate for the first time that the pace at which neonatal and perinatal milestones are acquired is correlated with later cognitive performance as an adult. In addition, we find that life-long behavioral indexing stratifies mice within each genotype. Our expanded assessment reveals that diminished cognitive flexibility, as measured by reversal learning, is the most robust learning and memory impairment in both young and old Ts65Dn mice. Moreover, we find that reversal learning degrades with age and is therefore a useful biomarker for studying age-related decline in cognitive ability. Altogether, our results indicate that preclinical studies aiming to restore cognitive function in Ts65Dn should target both neonatal milestones and reversal learning in adulthood. Here we provide the quantitative framework for this type of approach.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aging; Alzheimer Disease; Cognition; Developmental disorder; Developmental milestones; Down syndrome; Mouse behavior; Mouse model; Reversal learning; Ts65Dn

Mesh:

Substances:

Year:  2016        PMID: 26854932      PMCID: PMC5716476          DOI: 10.1016/j.expneurol.2016.02.005

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  78 in total

Review 1.  The neurobiological basis of spontaneous alternation.

Authors:  Robert Lalonde
Journal:  Neurosci Biobehav Rev       Date:  2002-01       Impact factor: 8.989

2.  DEVELOPMENTAL COMPARISONS OF MENTALLY RETARDED AND NEUROTIC CHILDREN.

Authors:  R SCHILLACE
Journal:  Am J Ment Defic       Date:  1964-09

3.  Molecular characterization of the translocation breakpoints in the Down syndrome mouse model Ts65Dn.

Authors:  Laura G Reinholdt; Yueming Ding; Griffith J Gilbert; Griffith T Gilbert; Anne Czechanski; Jeffrey P Solzak; Randall J Roper; Mark T Johnson; Leah Rae Donahue; Cathleen Lutz; Muriel T Davisson
Journal:  Mamm Genome       Date:  2011-09-28       Impact factor: 2.957

4.  Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome.

Authors:  D M Holtzman; D Santucci; J Kilbridge; J Chua-Couzens; D J Fontana; S E Daniels; R M Johnson; K Chen; Y Sun; E Carlson; E Alleva; C J Epstein; W C Mobley
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

Review 5.  Behavioral profiles of inbred strains on novel olfactory, spatial and emotional tests for reference memory in mice.

Authors:  A Holmes; C C Wrenn; A P Harris; K E Thayer; J N Crawley
Journal:  Genes Brain Behav       Date:  2002-01       Impact factor: 3.449

6.  Phenotypic characterization of spatial cognition and social behavior in mice with 'knockout' of the schizophrenia risk gene neuregulin 1.

Authors:  C M P O'Tuathaigh; D Babovic; G J O'Sullivan; J J Clifford; O Tighe; D T Croke; R Harvey; J L Waddington
Journal:  Neuroscience       Date:  2007-05-21       Impact factor: 3.590

7.  Overexpression of Dyrk1A is implicated in several cognitive, electrophysiological and neuromorphological alterations found in a mouse model of Down syndrome.

Authors:  Susana García-Cerro; Paula Martínez; Verónica Vidal; Andrea Corrales; Jesús Flórez; Rebeca Vidal; Noemí Rueda; María L Arbonés; Carmen Martínez-Cué
Journal:  PLoS One       Date:  2014-09-04       Impact factor: 3.240

8.  Monoacylglycerol lipase inhibitor JZL184 improves behavior and neural properties in Ts65Dn mice, a model of down syndrome.

Authors:  Larisa V Lysenko; Jeesun Kim; Cassandra Henry; Anna Tyrtyshnaia; Rebecca A Kohnz; Francisco Madamba; Gabriel M Simon; Natalia E Kleschevnikova; Daniel K Nomura; R Alan B Ezekowitz; Alexander M Kleschevnikov
Journal:  PLoS One       Date:  2014-12-04       Impact factor: 3.240

9.  Prevention of developmental delays in a Down syndrome mouse model.

Authors:  Laura Toso; Irene Cameroni; Robin Roberson; Daniel Abebe; Stephanie Bissell; Catherine Y Spong
Journal:  Obstet Gynecol       Date:  2008-12       Impact factor: 7.623

10.  What is the Most Sensitive Measure of Water Maze Probe Test Performance?

Authors:  Hamid R Maei; Kirill Zaslavsky; Cátia M Teixeira; Paul W Frankland
Journal:  Front Integr Neurosci       Date:  2009-03-09
View more
  16 in total

1.  Proteomic analysis of six- and twelve-month hippocampus and cerebellum in a murine Down syndrome model.

Authors:  Guido N Vacano; David S Gibson; Abdullah Arif Turjoman; Jeremy W Gawryluk; Jonathan D Geiger; Mark Duncan; David Patterson
Journal:  Neurobiol Aging       Date:  2017-11-26       Impact factor: 4.673

2.  Absence of Prenatal Forebrain Defects in the Dp(16)1Yey/+ Mouse Model of Down Syndrome.

Authors:  Joseph W Goodliffe; Jose Luis Olmos-Serrano; Nadine M Aziz; Jeroen L A Pennings; Faycal Guedj; Diana W Bianchi; Tarik F Haydar
Journal:  J Neurosci       Date:  2016-03-09       Impact factor: 6.167

3.  Epigallocatechin gallate: A useful therapy for cognitive disability in Down syndrome?

Authors:  Fiorenza Stagni; Andrea Giacomini; Marco Emili; Sandra Guidi; Elisabetta Ciani; Renata Bartesaghi
Journal:  Neurogenesis (Austin)       Date:  2017-02-02

4.  Sexually dimorphic DYRK1A overexpression on postnatal day 15 in the Ts65Dn mouse model of Down syndrome: Effects of pharmacological targeting on behavioral phenotypes.

Authors:  Laura E Hawley; Faith Prochaska; Megan Stringer; Charles R Goodlett; Randall J Roper
Journal:  Pharmacol Biochem Behav       Date:  2022-05-14       Impact factor: 3.697

5.  Behavioral Phenotyping for Down Syndrome in Mice.

Authors:  Randall J Roper; Charles R Goodlett; María Martínez de Lagrán; Mara Dierssen
Journal:  Curr Protoc Mouse Biol       Date:  2020-09

6.  Lifespan analysis of brain development, gene expression and behavioral phenotypes in the Ts1Cje, Ts65Dn and Dp(16)1/Yey mouse models of Down syndrome.

Authors:  Nadine M Aziz; Faycal Guedj; Jeroen L A Pennings; Jose Luis Olmos-Serrano; Ashley Siegel; Tarik F Haydar; Diana W Bianchi
Journal:  Dis Model Mech       Date:  2018-06-12       Impact factor: 5.758

7.  Deleterious Effects of Chronic Folate Deficiency in the Ts65Dn Mouse Model of Down Syndrome.

Authors:  Susan Helm; Morgan Blayney; Taylor Whited; Mahjabin Noroozi; Sen Lin; Semira Kern; David Green; Ahmad Salehi
Journal:  Front Cell Neurosci       Date:  2017-06-09       Impact factor: 5.505

8.  Early neurotrophic pharmacotherapy rescues developmental delay and Alzheimer's-like memory deficits in the Ts65Dn mouse model of Down syndrome.

Authors:  Syed Faraz Kazim; Julie Blanchard; Riccardo Bianchi; Khalid Iqbal
Journal:  Sci Rep       Date:  2017-04-03       Impact factor: 4.379

9.  Correction of cognitive deficits in mouse models of Down syndrome by a pharmacological inhibitor of DYRK1A.

Authors:  Thu Lan Nguyen; Arnaud Duchon; Antigoni Manousopoulou; Nadège Loaëc; Benoît Villiers; Guillaume Pani; Meltem Karatas; Anna E Mechling; Laura-Adela Harsan; Emmanuelle Limanton; Jean-Pierre Bazureau; François Carreaux; Spiros D Garbis; Laurent Meijer; Yann Herault
Journal:  Dis Model Mech       Date:  2018-09-27       Impact factor: 5.758

Review 10.  Rodent models in Down syndrome research: impact and future opportunities.

Authors:  Yann Herault; Jean M Delabar; Elizabeth M C Fisher; Victor L J Tybulewicz; Eugene Yu; Veronique Brault
Journal:  Dis Model Mech       Date:  2017-10-01       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.